These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25293387)

  • 21. Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study.
    Cuspidi C; Muiesan ML; Valagussa L; Salvetti M; Di Biagio C; Agabiti-Rosei E; Magnani B; Zanchetti A;
    J Hypertens; 2002 Nov; 20(11):2293-300. PubMed ID: 12409969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting nocturnal hypertension in type 2 diabetes mellitus.
    Rossen NB; Knudsen ST; Fleischer J; Hvas AM; Ebbehøj E; Poulsen PL; Hansen KW
    Hypertension; 2014 Nov; 64(5):1080-7. PubMed ID: 25259747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently?
    Mahabala C; Kamath P; Bhaskaran U; Pai ND; Pai AU
    Vasc Health Risk Manag; 2013; 9():125-33. PubMed ID: 23569382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
    Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild-to-moderate essential hypertension.
    Küppers HE; Jäger BA; Luszick JH; Gräve MA; Hughes PR; Kaan EC
    J Hypertens; 1997 Jan; 15(1):93-7. PubMed ID: 9050976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of a missed dose of trandolapril and enalapril on blood pressure control in hypertensive patients.
    Vaur L; Dutrey-Dupagne C; Boussac J; Genes N; Bouvier d'Yvoire M; Elkik F; Meredith PA
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):127-31. PubMed ID: 7564352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension.
    Himmelmann A; Keinänen-Kiukaanniemi S; Wester A; Redón J; Asmar R; Hedner T;
    Blood Press; 2001; 10(1):43-51. PubMed ID: 11332334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of enalapril and isradipine alone and in combination on blood pressure, renal function and echocardiographic parameters in mild hypertension.
    De Rosa ML; Maddaluno G; Lionetti F; Di Palma U; Albanese L; Cardace P; Baiano A; Vigorito C
    Int J Cardiol; 2000 Jun; 74(1):77-84. PubMed ID: 10854683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
    Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
    Agrawal R; Marx A; Haller H
    J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular remodelling and cardiac chamber sizes in long-term, normoalbuminuric type 1 diabetes patients with and without cardiovascular autonomic neuropathy.
    Hjortkjær HØ; Jensen T; Hilsted J; Mogensen UM; Corinth H; Rossing P; Køber L; Kofoed KF
    J Diabetes Complications; 2019 Feb; 33(2):171-177. PubMed ID: 30355473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients.
    Mancia G; Omboni S; Agabiti-Rosei E; Casati R; Fogari R; Leonetti G; Montemurro G; Nami R; Pessina AC; Pirrelli A; Zanchetti A
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):926-31. PubMed ID: 10836728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
    Leenen FH; Myers MG; Joyner CD; Toal CB
    Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial.
    Sidelmann Christensen A; Storgaard H; Hædersdal S; Hansen T; Knop FK; Vilsbøll T
    BMJ Open; 2018 Oct; 8(10):e022517. PubMed ID: 30287671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reassessment of circadian profile of blood pressure and heart rate in diabetic patients with autonomic neuropathy.
    Zoneraich S; Lodha A; Tibaldi J; Hyman RB; Mollura JL
    J Cardiol; 1995 Feb; 25(2):95-9. PubMed ID: 7897613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of acetazolamide on obstructive sleep apnoea in highlanders: protocol for a randomised, placebo-controlled, double-blinded crossover trial.
    Tan L; Furian M; Li T; Tang X
    BMJ Open; 2022 Mar; 12(3):e057113. PubMed ID: 35256446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combined treatment of arterial hypertension (results of the international program CLIP-ACCORD)].
    Chazova IE; Ratova LG
    Ter Arkh; 2009; 81(5):60-4. PubMed ID: 19537589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy.
    Gambardella S; Frontoni S; Spallone V; Maiello MR; Civetta E; Lanza G; Sandric S; Menzinger G; Lanza GA
    Am J Hypertens; 1993 Feb; 6(2):97-102. PubMed ID: 8471236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An inpatient trial of the safety and efficacy of losartan compared with placebo and enalapril in patients with essential hypertension.
    Byyny RL; Merrill DD; Bradstreet TE; Sweet CS
    Cardiovasc Drugs Ther; 1996 Jul; 10(3):313-9. PubMed ID: 8877074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.